Esperion Therapeutics Inc (ESPR) Common Stock USD0.001

Sell:$1.13Buy:$1.14$0.03 (2.56%)

NASDAQ:0.48%
Prices delayed by at least 15 minutes
Sell:$1.13
Buy:$1.14
Change:$0.03 (2.56%)
Prices delayed by at least 15 minutes
Sell:$1.13
Buy:$1.14
Change:$0.03 (2.56%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 June 2025
Sheldon L KoenigPresident/CEO
Sell
Tax related
30,474$1.11$33,795.671,541,488
17 June 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
7,229$1.15$8,327.81474,473
17 June 2025
Benjamin LookerGeneral Counsel
Sell
Tax related
6,422$1.15$7,398.14401,241
17 April 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
8$0.96$7.71481,702
17 April 2025
Eric WarrenChief Level Officer
Sell
Tax related
108$0.98$105.62370,218
18 March 2025
Sheldon L KoenigPresident/CEO
Sell
Tax related
13,047$1.50$19,622.691,571,962
18 March 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
3,535$1.48$5,242.41481,710
18 March 2025
Eric WarrenChief Level Officer
Sell
Tax related
2,433$1.49$3,617.87370,326
19 February 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
11$1.86$20.46240,671
19 February 2025
Eric WarrenChief Level Officer
Sell
Tax related
239$1.87$446.45159,759

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 June 2025
Sheldon L KoenigPresident/CEO
Sell
Tax related
30,474$1.11$33,795.671,541,488
17 December 2024
Sheldon L KoenigPresident/CEO
Sell
Tax related
12,447$2.47$30,694.30739,819
17 September 2024
Sheldon L KoenigPresident/CEO
Sell
Tax related
14,550$1.80$26,131.80752,266
18 March 2025
Sheldon L KoenigPresident/CEO
Sell
Tax related
13,047$1.50$19,622.691,571,962
17 June 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
7,229$1.15$8,327.81474,473

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.